Navigation Links
Top-Line Preliminary Data From Phase II/III Study of Corthera's Relaxin in Acute Heart Failure to be Presented in Satellite Symposium at AHA Scientific Sessions 2008
Date:11/3/2008

SAN MATEO, Calif., Nov. 3 /PRNewswire/ -- Top-line preliminary data from a Phase II/III clinical trial of Corthera's investigational drug relaxin for the treatment of acute heart failure will be presented next week at a satellite symposium at the American Heart Association's (AHA) Scientific Sessions 2008 in New Orleans.

John R. Teerlink, M.D., Professor of Medicine, University of California San Francisco, will present the data from the multicenter, international Pre/RELAX-AHF study as part of a symposium entitled "Tailoring Therapy to Presentation" that will focus on new approaches to the treatment of acute heart failure. The symposium will take place from 6 a.m. CST to 8 a.m. CST on Monday, Nov. 10, in the Grand Ballroom of the Sheraton New Orleans Hotel.

According to the AHA, heart failure is a costly syndrome contributing to more than 3 million hospitalizations each year in the U.S. The great majority of patients with acute heart failure have fluid accumulation in the lungs (congestion) that causes shortness of breath and other complications. For these patients, the current standard of care includes diuretics and vasodilators. Both of these classes of agents have been associated with renal impairment, hypotension and adverse outcomes.

About Relaxin

Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated levels of relaxin modulate increases in renal and cardiac function that meet the increased hemodynamic demands of pregnancy. Consistent with this natural role of the hormone, pharmaceutically manufactured relaxin has been shown to have these effects in multiple human studies of men and non-pregnant women. Data from a pilot study in patients with heart failure support the expectation that these effects may be beneficial in relieving the signs and symptoms of heart failure.

About Corthera

Corthera Inc. is a biopharmaceutical company committed to acquiring, developing a
'/>"/>

SOURCE Corthera
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
2. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
3. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
4. YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION
5. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
6. CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Aidas Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer
9. Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial
10. Symmetry Medical Reports Preliminary Third Quarter Revenue
11. KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... (PRWEB) July 22, 2014 OHAUS ... portable, and mechanical balances and scales, proudly announces ... has won Laboratory Equipment magazine’s 2014 “Readers' Choice” ... second consecutive year the Explorer was voted the ... annual Readers’ Choice Awards celebrates “excellence in product ...
(Date:7/22/2014)... og SHENZHEN , Kina, 22. ... LTD, (BGI Tech), et datterselskab af BGI, verdens ... ny human whole exome-sekvenseringstjeneste baseret på Complete Genomics ... anset i branchen for at levere patenterede sekvenseringsteknologier ... alle typer varianter, blev købt af BGI i ...
(Date:7/22/2014)... SHENZHEN, China , 22 juli 2014 /PRNewswire/ ... dochtermaatschappij van BGI, ,s wereld grootste organisatie op het ... een nieuwe service ten behoeve van hele menselijke genoomsequentie ... Complete Genomics. In 2013 acquireerde BGI ... hoog aanzien staat vanwege de in eigen beheer ontwikkelde ...
(Date:7/22/2014)... Hussey Copper , a leader in copper manufacturing ... Pullman Regional Hospital,s conversion of more than 1,100 touch ... at a nominal cost.  This reasonably priced surface kills ... within 2 hours of exposure 1 and will aid ... in its facilities. Pullman Regional Hospital, in ...
Breaking Biology Technology:OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2BGI Tech lancerer Human Whole Exome-sekvenseringstjeneste på Complete Genomics avancerede platform 2BGI Tech introduceert service op gebied van hele menselijke exoomsequencing op geavanceerd Complete Genomics-platform 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3
... Therapeutics, Inc.,a privately-held company focused on improving the ... today that the company,has raised $15.5 million in ... was co-led by New Leaf Ventures and Clarus ... conjunction with the financing,Kathleen LaPorte, managing director, New ...
... ATLANTA and ST. LOUIS, Sept. 6 ... organization (GPO) serving St. Louis-,based Sisters of ... with Elekta,enabling members to begin purchasing Elekta,s ... ) Under the agreement, Mercy ...
... Primary Endpoint Could be Acceptable With Fewer ... Patients Than Originally Planned, ... CTIC ) (MTAX: CTIC) announced today that following,discussions with the ... for patients with aggressive non-Hodgkin,s lymphoma,(NHL) the Company has decided ...
Cached Biology Technology:Pearl Therapeutics Raises $15.5 Million in Private Financing 2Pearl Therapeutics Raises $15.5 Million in Private Financing 3Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions 2Discussions With FDA on Pixantrone EXTEND (PIX301) Trial Provide Path for NDA Submission 2Discussions With FDA on Pixantrone EXTEND (PIX301) Trial Provide Path for NDA Submission 3Discussions With FDA on Pixantrone EXTEND (PIX301) Trial Provide Path for NDA Submission 4
(Date:7/22/2014)... prevent their daughters from breeding, and kill their grandchildren ... desert creatures which live in groups with a dominant ... alpha female can flourish when it maintains the sole right ... life, also found in many animals such as ants and ... Dominant meerkats control breeding within their group through violence, by ...
(Date:7/21/2014)... part of a multinational, collaborative effort, researchers from Canada,s ... identify over 100 locations in the human genome associated ... the largest genomic study published on any psychiatric disorder ... , point to biological mechanisms and pathways that may ... treating the disorder, which has seen little innovation in ...
(Date:7/21/2014)... there are reasons mammoths and mastodons could have been ... research from the University of Cincinnati, the famously fuzzy ... before it was trendy at the end of ... Crowley, an assistant professor of geology and anthropology, shows ... likely were year-round residents and not nomadic migrants as ...
Breaking Biology News(10 mins):International team sheds new light on biology underlying schizophrenia 2International team sheds new light on biology underlying schizophrenia 3Mammoth and mastodon behavior was less roam, more stay at home 2Mammoth and mastodon behavior was less roam, more stay at home 3
... fumes, risk developing increased clumsiness and the result may ... of a study at the University of Gothenburg, Sweden, of ... in Sweden work full-time with welding, while many more carry ... has shown that the concentration of manganese in the air ...
... Murphy works with some of the most powerful tools in ... These constructions sound a bit like socket wrenches, which can ... or to loosen a rusted-tight one-inch bolt using a very ... associate professor of biomedical engineering and orthopedics and rehabilitation at ...
... of threatened loggerhead sea turtles has revealed two previously unknown ... important habitat for at least three separate populations of the ... Biological Conservation . The two sites, located ... and the northern tip of the Yucatan Peninsula, were found ...
Cached Biology News:Increased clumsiness in former welders 2Smallest tools could give biggest results in bone repair 2Smallest tools could give biggest results in bone repair 3Satellite tracking reveals sea turtle feeding hotspots 2Satellite tracking reveals sea turtle feeding hotspots 3